UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 252

Sortiert nach

Acid β-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α-synuclein processing

Annals of neurology, 2011-06, Vol.69 (6), p.940-953

2011

Volltextzugriff (PDF)

Multi-system disorders of glycosphingolipid and ganglioside metabolism

Journal of lipid research, 2010-07, Vol.51 (7), p.1643-1675

2010

Volltextzugriff (PDF)

Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice

Human molecular genetics, 2014-08, Vol.23 (15), p.3943-3957

2014

Volltextzugriff (PDF)

Substrate compositional variation with tissue/region and Gba1 mutations in mouse models--implications for Gaucher disease

PloS one, 2013-03, Vol.8 (3), p.e57560

2013

Volltextzugriff (PDF)

Assessment and regression analysis on instant catapult steam explosion pretreatment of corn stover

Bioresource technology, 2014-08, Vol.166, p.368-372

2014

Volltextzugriff (PDF)

Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model

PloS one, 2010-05, Vol.5 (5), p.e10750

2010

Volltextzugriff (PDF)

Gaucher disease: transcriptome analyses using microarray or mRNA sequencing in a Gba1 mutant mouse model treated with velaglucerase alfa or imiglucerase

PloS one, 2013-10, Vol.8 (10), p.e74912

2013

Volltextzugriff (PDF)

Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model

PloS one, 2014-12, Vol.9 (12), p.e116023-e116023

2014

Volltextzugriff (PDF)

Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies

Cell, 2011-07, Vol.146 (1), p.37-52

2011

Volltextzugriff (PDF)

Microbial production of 1,3-propanediol from glycerol by Klebsiella pneumoniae under micro-aerobic conditions up to a pilot scale

Biotechnology letters, 2007-08, Vol.29 (8), p.1281-1285

2007

Volltextzugriff (PDF)

In vivo and ex vivo evaluation of L-type calcium channel blockers on acid beta-glucosidase in Gaucher disease mouse models

PloS one, 2009-10, Vol.4 (10), p.e7320-e7320

2009

Volltextzugriff (PDF)

Global gene expression profile progression in Gaucher disease mouse models

BMC genomics, 2011-01, Vol.12 (1), p.20-20, Article 20

2011

Volltextzugriff (PDF)

LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport In Vitro and In Vivo

Arteriosclerosis, thrombosis, and vascular biology, 2018-05, Vol.38 (5), p.1191

2018

Volltextzugriff (PDF)

Ex Vivo and in Vivo Effects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease

The Journal of biological chemistry, 2012-02, Vol.287 (6), p.4275-4287

2012

Volltextzugriff (PDF)

Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model

Human molecular genetics, 2015-12, Vol.24 (24), p.7031-7048

2015

Volltextzugriff (PDF)

Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits

Human molecular genetics, 2010-03, Vol.19 (6), p.1088-1097

2010

Volltextzugriff (PDF)

Gaucher disease: Chemotactic factors and immunological cell invasion in a mouse model

Molecular genetics and metabolism, 2014-02, Vol.111 (2), p.163-171

2014

Volltextzugriff (PDF)

Reversal of advanced disease in lysosomal acid lipase deficient mice: A model for lysosomal acid lipase deficiency disease

Molecular genetics and metabolism, 2014-07, Vol.112 (3), p.229-241

2014

Volltextzugriff (PDF)

Imatinib as Second-Line Treatment Drug for CML Patients Intolerant to Nilotinib

Zhongguo shi yan xue ye xue za zhi, 2018-04, Vol.26 (2), p.407

2018

Volltextzugriff (PDF)

Conditional expression of human acid β-glucosidase improves the visceral phenotype in a Gaucher disease mouse model

Journal of lipid research, 2006-10, Vol.47 (10), p.2161-2170

2006

Volltextzugriff (PDF)

Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid β-glucosidase residual activity levels

Molecular genetics and metabolism, 2008-06, Vol.94 (2), p.190-203

2008

Volltextzugriff (PDF)

Fine-tuning of xylose metabolism in genetically engineered Saccharomyces cerevisiae by scattered integration of xylose assimilation genes

Biochemical and biophysical research communications, 2013-10, Vol.440 (2), p.241-244

2013

Volltextzugriff (PDF)

Viable mouse models of acid β-glucosidase deficiency: The defect in Gaucher disease

The American journal of pathology, 2003-11, Vol.163 (5), p.2093-2101

2003

Volltextzugriff (PDF)

Reconstitution of TCP80/NF90 Translation Inhibition Activity in Insect Cells

Molecular genetics and metabolism, 2000-06, Vol.70 (2), p.106-115

2000

Volltextzugriff (PDF)

Translation modulation of acid β-glucosidase in HepG2 cells: participation of the PKC pathway

Molecular genetics and metabolism, 2005-03, Vol.84 (3), p.252-264

2005

Volltextzugriff (PDF)

1 – 25 von 252

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(226)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Life Sciences & Biomedicine
(56)
Animals
(45)
Humans
(43)
Male
(30)
Mice
(23)
Female
(21)
Disease Models, Animal
(18)
Science & Technology - Other Topics
(16)
Physical Sciences
(15)
Aged
(14)
General & Internal Medicine
(14)
Multidisciplinary Sciences
(14)
Technology
(14)
Medicine, General & Internal
(13)
Middle Aged
(13)
Genetics & Heredity
(11)
Biochemistry & Molecular Biology
(10)
Cells, Cultured
(10)
Gaucher Disease - Genetics
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acid β-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α-synuclein processing

Multi-system disorders of glycosphingolipid and ganglioside metabolism

Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice

Substrate compositional variation with tissue/region and Gba1 mutations in mouse models--implications for Gaucher disease

Assessment and regression analysis on instant catapult steam explosion pretreatment of corn stover

Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model

Gaucher disease: transcriptome analyses using microarray or mRNA sequencing in a Gba1 mutant mouse model treated with velaglucerase alfa or imiglucerase

Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model

Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies

Microbial production of 1,3-propanediol from glycerol by Klebsiella pneumoniae under micro-aerobic conditions up to a pilot scale

In vivo and ex vivo evaluation of L-type calcium channel blockers on acid beta-glucosidase in Gaucher disease mouse models

Global gene expression profile progression in Gaucher disease mouse models

LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport In Vitro and In Vivo

Ex Vivo and in Vivo Effects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease

Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model

Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits

Gaucher disease: Chemotactic factors and immunological cell invasion in a mouse model

Reversal of advanced disease in lysosomal acid lipase deficient mice: A model for lysosomal acid lipase deficiency disease

Imatinib as Second-Line Treatment Drug for CML Patients Intolerant to Nilotinib

Conditional expression of human acid β-glucosidase improves the visceral phenotype in a Gaucher disease mouse model

Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid β-glucosidase residual activity levels

Fine-tuning of xylose metabolism in genetically engineered Saccharomyces cerevisiae by scattered integration of xylose assimilation genes

Viable mouse models of acid β-glucosidase deficiency: The defect in Gaucher disease

Reconstitution of TCP80/NF90 Translation Inhibition Activity in Insect Cells

Translation modulation of acid β-glucosidase in HepG2 cells: participation of the PKC pathway

Suchergebnisse filtern